Authors
Tatiana Lopes, David CD. Hope, Jose M. Ramos-Pittol, Anna Curtis, Jed V. Shrewsbury, Iona Davies, Zijing Zhou, Alessandro Sardini, James S. Minnion, Dirk Dormann, Gavin A. Bewick, Kevin G. Murphy, David Carling, Stephen R. Bloom, Tricia MM. Tan, Bryn M. Owen
Lab
Journal
Molecular Metabolism
Abstract
Glucagon has long been proposed as a component of multi-agonist obesity therapeutics due to its ability to induce energy expenditure and cause weight
Keywords/Topics
Glucagon;Obesity;MAFLD;Drug Side - effect;Lean mass;Muscle mass
BIOSEB Instruments Used:
Grip strength test (BIO-GS4)
Source :
https://www.sciencedirect.com/science/article/pii/S2212877824001558
Congrès & Meetings 2026 